ArticleJournal for immunotherapy of cancer2022

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.

Rebekka Bitsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.